ViaShield
PreclinicalBiologic
ViaShield is one of 3 biologic programs targeting HIE. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
2 competitors in HIE
#DrugCompanyPhaseTrials
1Scemblix
NovartisPhase 3
Gleevec
NovartisPhase 3
ViaShield
GGlobus Medical Inc
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
HIE1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for ViaShield. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- GGlobus Medical Inc